Vertex to Buy Kidney Disease Drug Developer for $4.9 Billion

Vertex to Buy Kidney Disease Drug Developer for $4.9 Billion

Vertex to Buy Kidney Disease Drug Developer for $4.9 Billion
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

Related Keywords

Boston , Massachusetts , United States , Switzerland , Swiss , Reshma Kewalramani , Chinook Therapeutics Inc , Alpine Immune Sciences Inc , Bloomberg Vertex Pharmaceuticals Inc , Alpine Immune Sciences , Crispr Therapeutics , Alpine Immune Is Said , Weigh Options After Takeover , Chief Executive Officer Reshma Kewalramani ,